Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.
García
J R
JR
IPF PharmaCeuticals GmbH, 30625 Hannover, Germany.
Krause
A
A
Schulz
S
S
Rodríguez-Jiménez
F J
FJ
Klüver
E
E
Adermann
K
K
Forssmann
U
U
Frimpong-Boateng
A
A
Bals
R
R
Forssmann
W G
WG
D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology*; D002630:Chemotactic Factors; D018076:DNA, Complementary / Q000737:chemistry; D004357:Drug Synergism; D004847:Epithelial Cells / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects; D015870:Gene Expression; D006801:Humans; D008168:Lung / Q000378:metabolism; D008969:Molecular Sequence Data; D009000:Monocytes; D011552:Pseudomonas Infections / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D023083:beta-Defensins / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002630:Chemotactic Factors; D018076:DNA, Complementary; D012333:RNA, Messenger; D023083:beta-Defensins; D013755:Tetradecanoylphorbol Acetate